Clinical Trial: Switching From Oral Dopamine Agonists to Rotigotine

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: A Method to Switch From Oral Dopamine Agonists to Rotigotine in Patients With Restless Legs Syndrome

Brief Summary:

The primary objective is to demonstrate safety and tolerability of switching patients with Restless Legs Syndrome (RLS) from an oral dopamine agonist to rotigotine.

As a secondary objective, the investigators will evaluate control of RLS symptoms on rotigotine compared to the prior oral regimen.